\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ unknown\\.\ \(0\)\
\-\ canca\\ neg\\.\ \(0\)\
\-\ the\\ patient\\ was\\ intubated\\ and\\ subsequently\\ underwent\\ tracheostomy\\.\\ \\ she\\ is\\ currently\\ still\\ in\\ the\\ intensive\\ care\\ unit\\,\\ day\\ 20\\.\ \(0\)\
\-\ diffuse\\,\\ bilateral\\,\\ hazy\\ airspace\\ opacities\\ predominately\\ in\\ the\\ mid\\ to\\ low\\ lung\\ zones\\.\\ \\ overall\\,\\ these\\ findings\\ are\\ nonspecific\\,\\ but\\ with\\ known\\ history\\ of\\ pulmonary\\ hemorrhage\\ after\\ bronchoscopy\\ or\\ clinical\\ findings\\ of\\ hemoptysis\\ and\\ anemia\\,\\ these\\ findings\\ are\\ consistent\\ with\\ diffuse\\ pulmonary\\ hemorrhage\\.\ \(0\)\
\-\ pulmonary\\ hemorrhage\\ and\\ pulmonary\\-renal\\ syndrome\ \(0\)\
\-\ pulmonary\\ hemorrhage\\ with\\ renal\\ disease\\:\\ \\ wegener\\â\\€\\™s\\ granulomatosis\\,\\ systemic\\ lupus\\ erythematosus\\,\\ goodpasture\\â\\€\\™s\\ syndrome\\,\\ other\\ vasculitides\ \(0\)\
\-\ pulmonary\\ hemorrhage\\ without\\ renal\\ disease\\:\\ \\ anitcoagulation\\,\\ pulmonary\\ infection\\ or\\ neoplasm\\,\\ pulmonary\\ embolism\\,\\ idiopathic\\ pulmonary\\ hemosiderosis\\,\\ trauma\\,\\ bone\\ marrow\\ transplantation\ \(0\)\
\-\ 42\\ year\\ old\\ female\\ with\\ history\\ of\\ scleroderma\\ with\\ new\\ onset\\ seizures\\ and\\ acute\\ renal\\ failure\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.5177744674715702\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.3159573232835164\ \(0\)\
\-\ renal\\:\\ 0\\.2350986459850291\ \(0\)\
\-\ canca\\:\\ 0\\.15093819475641287\ \(0\)\
\-\ anitcoagulation\\:\\ 0\\.14422950309662338\ \(0\)\
\-\ findings\\:\\ 0\\.1397446762499124\ \(0\)\
\-\ goodpasture\\:\\ 0\\.135777551169723\ \(0\)\
\-\ vasculitides\\:\\ 0\\.13021039275724305\ \(0\)\
\-\ hemosiderosis\\:\\ 0\\.13021039275724305\ \(0\)\
\-\ diffuse\\:\\ 0\\.11837904323113786\ \(0\)\
\-\ tracheostomy\\:\\ 0\\.11653244232859641\ \(0\)\
\-\ intensive\\:\\ 0\\.11458364315162288\ \(0\)\
\-\ hazy\\:\\ 0\\.11458364315162288\ \(0\)\
\-\ syndrome\\:\\ 0\\.1137991250557235\ \(0\)\
\-\ erythematosus\\:\\ 0\\.11203311695484806\ \(0\)\
\-\ zones\\:\\ 0\\.11126341215248113\ \(0\)\
\-\ transplantation\\:\\ 0\\.1098237506688069\ \(0\)\
\-\ predominately\\:\\ 0\\.10669261509321945\ \(0\)\
\-\ these\\:\\ 0\\.10659558691001993\ \(0\)\
\-\ wegener\\:\\ 0\\.10558916165436083\ \(0\)\
\-\ scleroderma\\:\\ 0\\.10558916165436083\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.10406078323176005\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.1031150590090174\ \(0\)\
\-\ neg\\:\\ 0\\.1017906988244829\ \(0\)\
\-\ airspace\\:\\ 0\\.10137179874190651\ \(0\)\
\-\ unit\\:\\ 0\\.10096324293567116\ \(0\)\
\-\ intubated\\:\\ 0\\.09979482800987563\ \(0\)\
\-\ lupus\\:\\ 0\\.0983551665262014\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.09767973929782212\ \(0\)\
\-\ with\\:\\ 0\\.09240638572211746\ \(0\)\
\-\ opacities\\:\\ 0\\.09011133897201266\ \(0\)\
\-\ nonspecific\\:\\ 0\\.08870662083705731\ \(0\)\
\-\ overall\\:\\ 0\\.08671512313453274\ \(0\)\
\-\ anemia\\:\\ 0\\.08671512313453274\ \(0\)\
\-\ embolism\\:\\ 0\\.08556222219906141\ \(0\)\
\-\ 42\\:\\ 0\\.08389870025239404\ \(0\)\
\-\ systemic\\:\\ 0\\.08375544680800845\ \(0\)\
\-\ still\\:\\ 0\\.08361342302208791\ \(0\)\
\-\ subsequently\\:\\ 0\\.08052623347357997\ \(0\)\
\-\ idiopathic\\:\\ 0\\.07983673081307273\ \(0\)\
\-\ disease\\:\\ 0\\.07923685688682593\ \(0\)\
\-\ marrow\\:\\ 0\\.07843463045669552\ \(0\)\
\-\ and\\:\\ 0\\.07801196798786618\ \(0\)\
\-\ seizures\\:\\ 0\\.07704675514821895\ \(0\)\
\-\ currently\\:\\ 0\\.07250221064419685\ \(0\)\
\-\ history\\:\\ 0\\.07211917213746316\ \(0\)\
\-\ failure\\:\\ 0\\.07165714173533932\ \(0\)\
\-\ are\\:\\ 0\\.07162774681530192\ \(0\)\
\-\ unknown\\:\\ 0\\.07152039988704338\ \(0\)\
\-\ mid\\:\\ 0\\.06792394094522883\ \(0\)\
\-\ care\\:\\ 0\\.06743806255614747\ \(0\)\
\-\ or\\:\\ 0\\.0656679953854227\ \(0\)\
\-\ new\\:\\ 0\\.06529533216149824\ \(0\)\
\-\ underwent\\:\\ 0\\.06501724713711651\ \(0\)\
\-\ neoplasm\\:\\ 0\\.06443029963546501\ \(0\)\
\-\ known\\:\\ 0\\.0611060365491902\ \(0\)\
\-\ onset\\:\\ 0\\.06060569740407409\ \(0\)\
\-\ day\\:\\ 0\\.06012004540594386\ \(0\)\
\-\ clinical\\:\\ 0\\.05981520356856661\ \(0\)\
\-\ lung\\:\\ 0\\.057413977105105804\ \(0\)\
\-\ infection\\:\\ 0\\.05701250268972049\ \(0\)\
\-\ the\\:\\ 0\\.05649819728271773\ \(0\)\
\-\ she\\:\\ 0\\.056183664828097855\ \(0\)\
\-\ of\\:\\ 0\\.05541072353915947\ \(0\)\
\-\ trauma\\:\\ 0\\.0548137641758905\ \(0\)\
\-\ low\\:\\ 0\\.054157200333185405\ \(0\)\
\-\ bone\\:\\ 0\\.051498043991789914\ \(0\)\
\-\ physical\\:\\ 0\\.051176368353882104\ \(0\)\
\-\ consistent\\:\\ 0\\.051176368353882104\ \(0\)\
\-\ acute\\:\\ 0\\.05105733424717581\ \(0\)\
\-\ bilateral\\:\\ 0\\.050724648431105517\ \(0\)\
\-\ without\\:\\ 0\\.04978323017311548\ \(0\)\
\-\ other\\:\\ 0\\.04901435733401553\ \(0\)\
\-\ exam\\:\\ 0\\.047512207190833496\ \(0\)\
\-\ in\\:\\ 0\\.046958615171710245\ \(0\)\
\-\ but\\:\\ 0\\.04667230305129951\ \(0\)\
\-\ after\\:\\ 0\\.04578650709365246\ \(0\)\
\-\ female\\:\\ 0\\.04554391854711499\ \(0\)\
\-\ was\\:\\ 0\\.0328932422458517\ \(0\)\
\-\ patient\\:\\ 0\\.03069789526839546\ \(0\)\
\-\ year\\:\\ 0\\.029086834072907256\ \(0\)\
\-\ old\\:\\ 0\\.027933429367474897\ \(0\)\
\-\ is\\:\\ 0\\.025847294019333392\ \(0\)\
\-\ to\\:\\ 0\\.023595444313900295\ \(0\)\
